Found: 3
Select item for more details and to access through your institution.
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.
- Published in:
- Biomedicines, 2024, v. 12, n. 2, p. 413, doi. 10.3390/biomedicines12020413
- By:
- Publication type:
- Article
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2023, v. 27, n. 3, p. 190, doi. 10.5114/wo.2023.133545
- By:
- Publication type:
- Article
Prognostic value of pan-immuneinflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2023, v. 27, n. 4, p. 242, doi. 10.5114/wo.2023.134786
- By:
- Publication type:
- Article